347 Results

People

  1. Mauro
    Mauro
  2. Clarkson
    Clarkson
  3. Berman
    Berman
  4. O'Reilly
    O'Reilly
  5. Strife
    Strife
  6. Wisniewski
    Wisniewski
  7. Kernan
    Kernan
  8. Sawyers
    Sawyers
  9. Scheinberg
    Scheinberg
  10. Papadopoulos
    Papadopoulos

Groups

  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)
  7. Tow Center for Developmental Oncology (TCDO) (77)
  8. Molecular Pharmacology and Chemistry Program Faculty (71)
  9. Human Oncology and Pathogenesis Program (47)
  10. Pediatrics, Department of (46)
  1. "chronic myeloid leukemia"
Formats
  1. Journal Article (300)
  2. Meeting Abstract (18)
  3. Review (10)
  4. Conference Paper (8)
  5. Research Letter (6)
  6. Correspondence (2)
  7. Editorial (2)
  8. Guidelines (1)
Groups
  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)

More Groups

People
  1. Michael Mauro (56)
  2. Bayard Clarkson (40)
  3. Ellin Berman (24)
  4. Annabel Strife (20)
  5. Richard O'Reilly (20)
  6. David Wisniewski (18)

More People

Years
  1. 2025 (7)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Blood (29)
  2. Leukemia (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (19)
  4. Biology of Blood and Marrow Transplantation (17)
  5. Bone Marrow Transplantation (15)
  6. Cancer Research (14)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. Nature Publishing Group (51)
  3. American Society of Hematology (33)
  4. American Association for Cancer Research (20)
  5. John Wiley & Sons (12)
  6. Springer (12)

More Publishers

Results (347)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: Phase 1 study final results
    Journal Article

    Cortes, J. E.; Lang, F.; Rea, D.; Hochhaus, A.; Breccia, M.; Goh, Y. T.; Heinrich, M. C.; Hughes, T. P.; Janssen, J. J. W. M.; le Coutre, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results: CHRONIC MYELOID LEUKEMIA
    Journal Article

    Hochhaus, A.; Kim, D. W.; Cortes, J. E.; Sasaki, K.; Mauro, M. J.; Hughes, T. P.; Breccia, M.; Talpaz, M.; Minami, H.; Goh, Y. T.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Pharmacokinetic profile of novel reduced-dose Danziten(TM) (nilotinib tablets) versus Tasigna® (nilotinib capsules): In vivo bioequivalence and population pharmacokinetic analysis
    Journal Article

    Mauro, M.; Radich, J.; Jain, P.; Sequeira, D.; Bellanti, F.; Douer, D.
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save
  • The Association of HLA-E ligand and NKG2 receptor variation with relapse and mortality after haploidentical related donor transplantation
    Journal Article

    Petersdorf, E. W.; McKallor, C.; Malkki, M.; Hsu, K.; He, M.; Spellman, S. R.; Gooley, T.; Stevenson, P.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Analyzing determinants of premature trial discontinuation in leukemia clinical trials
    Journal Article

    Rotter, L. K.; Alhajahjeh, A.; Stempel, J. M.; Grimshaw, A. A.; Bewersdorf, J. P.; Blaha, O.; Kewan, T.; Podoltsev, N. A.; Shallis, R. M.; Mendez, L.; more...
    Leukemia and Lymphoma (2025)

    Fulltext@MSK | Save
  • Basophilia predicts poorer outcomes in essential thrombocythemia, polycythemia vera, primary myelofibrosis, and myeloproliferative neoplasm, unclassifiable
    Research Letter

    Yuen, L.; Gogakos, T.; Boiocchi, L.; Hobbs, G.; Hasserjian, R.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Impact of recent translational and therapeutic developments on clinical course of BCR::ABL1-positive and -negative myeloproliferative neoplasms
    Review

    Mughal, T. I.; Mascarenhas, J.; Rampal, R. K.; Bose, P.; Lion, T.; Ajufo, H.; Yacoub, A.; Meshinchi, S.; Masarova, L.; Mesa, R.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Dose-optimization study of 3 starting doses of ponatinib: Long-term results from the OPTIC trial
    Meeting Abstract

    Cortes, J.; Deininger, M.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; McCloskey, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Dose-escalation of second-line and first-line asciminib in chronic myeloid leukemia in chronic phase: The ASC2ESCALATE Phase II trial
    Journal Article

    Atallah, E. L.; Mauro, M. J.; Sasaki, K.; Levy, M. Y.; Koller, P.; Yang, D.; Laine, D.; Sabo, J.; Gu, E.; Cortes, J. E.
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
    Research Letter

    Ceyhan-Birsoy, O.; Fiala, E.; Rana, S.; Sheehan, M.; Kennedy, J.; Yelskaya, Z.; Rai, V.; Li, Y.; Yang, C.; Wong, D.; more...
    Haematologica (2024)

    Fulltext@MSK | Save